EGF and breast carcinoma: To investigate the signaling effects of EGF elicited against ER-positive breast cancer cells within the coculture system, we evaluated its effects on the downstream signaling components PI3K and Akt, employing specific inhibitors EGFR kinase activity (AG1478) and PI3K/Akt activation (wortmannin), respectively.